Clinical Trial Management System Ctms Market
Clinical Trial Management System (CTMS) Market Forecasts to 2028 – Global Analysis By Component (Hardware, Software, Services), Application (Patient Management Solutions, Data Management Solutions) and By Geography
|
Years Covered |
2020-2028 |
|
Estimated Year Value (2021) |
US $918.75 MN |
|
Projected Year Value (2028) |
US $2708.27 MN |
|
CAGR (2021 - 2028) |
16.7% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) Market is accounted for $918.75 million in 2021 and is expected to reach $2,708.27 million by 2028 growing at a CAGR of 16.7% during the forecast period. Clinical Trial Management System (CTMS) is a software system that is customizable and aims at managing the clinical trial data generated in clinical trials conducted by different pharmaceutical companies and clinical research organizations. The management system allows the ease in tracking and monitoring of patients involved in the clinical trials and analyzes huge amounts of data which helps in deciding the safety factors of the products undergoing clinical trials.
Market Dynamics:
Driver:
Availability of advanced CTMS solutions
The life science industry is witnessing a global increase in the number of clinical trials. The growth in the number of clinical trials can be attributed to factors such as the high prevalence of chronic diseases, the expiry of blockbuster drugs, the availability of government funds for clinical trials, and fierce competition in the pharmaceutical industry. In recent years, leading players have launched many CTMS solutions in the market that claim superior performance than their traditional counterparts. These products are cost-effective, easy to use, provide effective patient safety and regulatory compliance, and enhance the financial management capabilities of users. They enable organizations to implement a full-featured CTMS without the complex configuration and heavy capital investment associated with traditional solutions.
Restraint:
Financial constraints
The prevalence of financial constraints for clinical trials is often due to limited private funding, strict regulatory mandates, and financial outlook. This also includes ineffective site selection, poor study design & trial execution, safety issues, and dropouts due to practical or financial issues. Although R&D spending in the life science industry is rising, start-ups and SMEs still face budget constraints, which affect their decision to purchase CTMS solutions. Due to uncertainties and undue delays in product approvals and long gestation periods, private investors usually prefer established firms to invest in rather than start-ups and SMEs.
Opportunity:
Increased innovations by pharma companies
Even though the supply of technology has been increasing and the regulation of innovative methods is easing, pharmaceutical companies have been slow to use emerging technologies due to the uncertainty prevailing around this space and a highly fragmented supply market. Lately, pharma companies have increased expenditure on AI and big data analytics, given their transformative supremacy over the R&D process and cost savings. Fear of rivalry in the market and the need for business transformation and agility are key forces driving huge investments in R&D technologies. Hence, pharma companies must recognize outward innovation through supplier benchmarking in each of these categories and be involved in early engagement through co-development to stay competitive. This would provide ample opportunities for the market.
Threat:
Lack of skilled professionals
The lack of skilled professionals for handling advanced digital solutions in research teams is a major challenge faced by the CTMS market. With severe time constraints and increasing cost cuts, CROs and pharmaceutical companies are reluctant to invest in training their research employees. Hence, a huge gap exists between the available and required skilled manpower in the clinical research industry, restricting the adoption and utilization of complex software solutions in clinical trials. The development of user-friendly software solutions could act as a key growth opportunity for software vendors in this market.
The web-based (on-demand) segment is expected to be the largest during the forecast period
Web-based systems are the most preferred CTM systems. High growth rate is attributed to various advantages associated with web-based solution such as remote access to data and minimal technical issues. Web-based CTMS uses secure enterprise-class data centers to store, update, and back-up on a daily basis. Also, web-based software allows the centralization of data, which facilitates access to data from any location and they help minimize cost associated with system security, backups, upgrades, and uptime consistency.
The software segment is expected to have the highest CAGR during the forecast period
The CTMS software performs various critical functions such as comprehensive management of trial planning, country & site progress and monitoring activities among others. Also, rising number of clinical trials across the globe will increase the acceptance rate, thereby augmenting the industry value over the forecast timeframe. In addition, advancements in CTMS software to ensure effective management of clinical trials data generated by biotech and pharmaceutical companies will accelerate new product launch, thereby supplementing the industry demand.
Region with largest share:
North America is projected to hold the largest market share owing to the strong presence of major pharma and biopharmaceutical companies as well as CROs. Also, extensive drug development activities in the region will further stimulate the usage of clinical trial management system software to manage the data volume. Moreover, the growing clinical research activities in U.S. and rapid shift from manual data elucidation to real-time data analysis during clinical studies will further accelerate the expansion of the CTMS market. Growing concern regarding efficient management of large and confidential data volume will increase the acceptance of CTMS solutions and boost the industry progression in the region.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR due to increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, and the growing number of pharmaceutical companies and CROs in the region.
Key players in the market
Some of the key players profiled in the Clinical Trial Management System (CTMS) Market include IBM, Oracle, Bioclinica, Veeva Systems, Parexel International Corporation, PHARMASEAL, Advarra Technology Solutions, Merge Healthcare, Medidata Solutions, Bio-Optronics, Mednet Solutions, DZS Clinical Services (WDB Holdings Co. Ltd), Arisglobal, Mastercontrol, and Datastat.
Key developments:
In January 2020: Veeva System launched its Vault Payment, a new application for Vault CTMS that help in managing and reimbursement process to clinical research site. This launching strategy enabled company to add value to their existing services portfolio in clinical research and data management, thereby strengthening their business revenue and market presence.
In June 2019: Parexel International Corporation (US) launched an enhanced integrated outsourcing delivery model for functional service provider (FSP) services at the DIA 2019 Global Annual Meeting in San Diego, US.
In May 2019: Bio-optronics launched three products to the CCTrialSuite basket application, namely CCeSource, CCeReg & CCeConsent. These offer users with a range of benefits designed to increase efficiency, cost-effectiveness, and patient-centricity.
In January 2019: PHARMASEAL launched Engility CTMS, the first product to be released from its Engility B2B platform. This strategy enabled company to expand its service offerings and increase its revenue from its sales.
In June 2018: Bioclinica launched eClinical solution namely the SMART Technology Suite. It is available with medical imaging, electronic data capture and interactive response technology combined. SMART allows plug-in functionality with Bioclinica site & patient payments, cardiac safety (ECG and ABPM), and clinical event adjudication, as well as third-party providers.
Components Covered:
• Hardware
• Software
• Services
Delivery Modes Covered:
• Cloud-Based (Software as a Service (SaaS))
• Web-Based (On-Demand)
• Licensed Enterprise (On-Premises)
Deployments Covered:
• On-Site
• Enterprise-Wide
Applications Covered:
• Patient Management Solutions
• Data Management Solutions
• Site Management Solutions
• Document Management Solutions
End Users Covered:
• Healthcare Providers
• Medical Device Manufacturers
• Academic Research Centers
• Contract Research Organizations (CROs)
• Small & Mid-Sized Pharma-Biotech Companies
• Large Pharma-Biotech Companies
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Clinical Trial Management System (CTMS) Market, By Component
5.1 Introduction
5.2 Hardware
5.3 Software
5.4 Services
6 Global Clinical Trial Management System (CTMS) Market, By Delivery Mode
6.1 Introduction
6.2 Cloud-Based (Software as a Service (SaaS))
6.3 Web-Based (On-Demand)
6.4 Licensed Enterprise (On-Premises)
7 Global Clinical Trial Management System (CTMS) Market, By Deployment
7.1 Introduction
7.2 On-Site
7.3 Enterprise-Wide
8 Global Clinical Trial Management System (CTMS) Market, By Application
8.1 Introduction
8.2 Patient Management Solutions
8.3 Data Management Solutions
8.4 Site Management Solutions
8.5 Document Management Solutions
9 Global Clinical Trial Management System (CTMS) Market, By End User
9.1 Introduction
9.2 Healthcare Providers
9.2.1 Research Hospitals
9.2.2 Clinics
9.2.3 Cancer Centers
9.3 Medical Device Manufacturers
9.4 Academic Research Centers
9.5 Contract Research Organizations (CROs)
9.6 Small & Mid-Sized Pharma-Biotech Companies
9.7 Large Pharma-Biotech Companies
10 Global Clinical Trial Management System (CTMS) Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 IBM
12.2 Oracle
12.3 Bioclinica
12.4 Veeva Systems
12.5 Parexel International Corporation
12.6 PHARMASEAL
12.7 Advarra Technology Solutions
12.8 Merge Healthcare
12.9 Medidata Solutions
12.10 Bio-Optronics
12.11 Mednet Solutions
12.12 DZS Clinical Services (WDB Holdings Co. Ltd)
12.13 Arisglobal
12.14 Mastercontrol
12.15 Datastat
List of Tables
1 Global Clinical Trial Management System (CTMS) Market Outlook, By Region (2020-2028) ($MN)
2 Global Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
3 Global Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
4 Global Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
5 Global Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
6 Global Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
7 Global Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
8 Global Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
9 Global Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
10 Global Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
11 Global Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
12 Global Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
13 Global Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
14 Global Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
15 Global Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
16 Global Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
17 Global Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
18 Global Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
19 Global Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
20 Global Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
21 Global Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
22 Global Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
23 Global Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
24 Global Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
25 Global Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
26 Global Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
27 Global Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
28 North America Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
29 North America Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
30 North America Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
31 North America Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
32 North America Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
33 North America Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
34 North America Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
35 North America Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
36 North America Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
37 North America Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
38 North America Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
39 North America Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
40 North America Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
41 North America Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
42 North America Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
43 North America Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
44 North America Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
45 North America Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
46 North America Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
47 North America Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
48 North America Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
49 North America Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
50 North America Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
51 North America Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
52 North America Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
53 North America Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
54 North America Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
55 Europe Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
56 Europe Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
57 Europe Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
58 Europe Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
59 Europe Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
60 Europe Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
61 Europe Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
62 Europe Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
63 Europe Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
64 Europe Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
65 Europe Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
66 Europe Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
67 Europe Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
68 Europe Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
69 Europe Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
70 Europe Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
71 Europe Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
72 Europe Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
73 Europe Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
74 Europe Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
75 Europe Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
76 Europe Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
77 Europe Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
78 Europe Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
79 Europe Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
80 Europe Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
81 Europe Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
82 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
83 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
84 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
85 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
86 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
87 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
88 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
89 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
90 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
91 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
92 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
93 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
94 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
95 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
96 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
97 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
98 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
99 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
100 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
101 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
102 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
103 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
104 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
105 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
106 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
107 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
108 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
109 South America Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
110 South America Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
111 South America Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
112 South America Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
113 South America Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
114 South America Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
115 South America Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
116 South America Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
117 South America Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
118 South America Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
119 South America Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
120 South America Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
121 South America Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
122 South America Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
123 South America Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
124 South America Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
125 South America Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
126 South America Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
127 South America Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
128 South America Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
129 South America Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
130 South America Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
131 South America Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
132 South America Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
133 South America Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
134 South America Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
135 South America Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
136 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
137 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
138 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
139 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
140 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
141 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
142 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
143 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
144 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
145 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
146 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
147 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
148 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
149 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
150 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
151 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
152 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
153 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
154 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
155 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
156 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
157 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
158 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
159 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
160 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
161 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
162 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
